Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zanger

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
Human Mutation|February 27, 2008
6-mercaptopurine and 9-(2-phosphonyl-methoxyethyl) adenine (PMEA) transport altered by two missense mutations in the drug transporter gene ABCC4Daniel Janke, Sherif Mehralivand, Dennis Strand, et al.
Frontiers in Immunology|August 14, 2018
β-Defensin 1 Is Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids <i>via</i> Farnesoid X Receptor and Constitutive Androstane ReceptorThomas Klag, Maria Thomas, Dirk Ehmann, et al.
The Journal of Infectious Diseases|July 29, 2010
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group studyHeather J Ribaudo, Huan Liu, Matthias Schwab, et al.
Journal of Hepatology|July 30, 2015
Inflammatory regulation of steroid sulfatase: A novel mechanism to control estrogen homeostasis and inflammation in chronic liver diseaseMengxi Jiang, Marcus Klein, Ulrich M Zanger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 2, 2019
Factors Affecting Interindividual Variability of Hepatic UGT2B17 Protein Expression Examined Using a Novel Specific Monoclonal AntibodyJean-Philippe Émond, Adrien Labriet, Sylvie Desjardins, et al.
Breast Cancer Research : BCR|January 29, 2021
Correction to: Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progressionHannah Asperger, Nadia Stamm, Berthold Gierke, et al.
Pharmacogenetics|June 1, 1996
Nomenclature for human CYP2D6 allelesA K Daly, J Brockmöller, F Broly, et al.
Acta Pharmaceutica Sinica. B|April 8, 2017
Regulation of drug metabolism and toxicity by multiple factors of genetics, epigenetics, lncRNAs, gut microbiota, and diseases: a meeting report of the 21<sup>st</sup> International Symposium on Microsomes and Drug Oxidations (MDO)Ai-Ming Yu, Magnus Ingelman-Sundberg, Nathan J Cherrington, et al.
The Lancet. Oncology|November 26, 2015
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient dataDidier Meulendijks, Linda M Henricks, Gabe S Sonke, et al.
Gut|January 30, 2020
TGF-β2 silencing to target biliary-derived liver diseasesAnne Dropmann, Steven Dooley, Bedair Dewidar, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Human Mutation|February 27, 2008
6-mercaptopurine and 9-(2-phosphonyl-methoxyethyl) adenine (PMEA) transport altered by two missense mutations in the drug transporter gene ABCC4Daniel Janke, Sherif Mehralivand, Dennis Strand, et al.
Frontiers in Immunology|August 14, 2018
β-Defensin 1 Is Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids <i>via</i> Farnesoid X Receptor and Constitutive Androstane ReceptorThomas Klag, Maria Thomas, Dirk Ehmann, et al.
The Journal of Infectious Diseases|July 29, 2010
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group studyHeather J Ribaudo, Huan Liu, Matthias Schwab, et al.
Journal of Hepatology|July 30, 2015
Inflammatory regulation of steroid sulfatase: A novel mechanism to control estrogen homeostasis and inflammation in chronic liver diseaseMengxi Jiang, Marcus Klein, Ulrich M Zanger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 2, 2019
Factors Affecting Interindividual Variability of Hepatic UGT2B17 Protein Expression Examined Using a Novel Specific Monoclonal AntibodyJean-Philippe Émond, Adrien Labriet, Sylvie Desjardins, et al.
Breast Cancer Research : BCR|January 29, 2021
Correction to: Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progressionHannah Asperger, Nadia Stamm, Berthold Gierke, et al.
Pharmacogenetics|June 1, 1996
Nomenclature for human CYP2D6 allelesA K Daly, J Brockmöller, F Broly, et al.
Acta Pharmaceutica Sinica. B|April 8, 2017
Regulation of drug metabolism and toxicity by multiple factors of genetics, epigenetics, lncRNAs, gut microbiota, and diseases: a meeting report of the 21<sup>st</sup> International Symposium on Microsomes and Drug Oxidations (MDO)Ai-Ming Yu, Magnus Ingelman-Sundberg, Nathan J Cherrington, et al.
The Lancet. Oncology|November 26, 2015
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient dataDidier Meulendijks, Linda M Henricks, Gabe S Sonke, et al.
Gut|January 30, 2020
TGF-β2 silencing to target biliary-derived liver diseasesAnne Dropmann, Steven Dooley, Bedair Dewidar, et al.
Pageof 21